Complete Medical Imaging Solution for Next-Generation Healthcare
Diagnostic Suite™ is a comprehensive solution for medical
imaging practices that is seamless, efficient and scalable. It provides a unified diagnostic
workspace with a viewer, multi-format reporting tools, and advanced image management
capability, leveraging cloud-native functionality to deliver a modernized evolution of the
traditional PACS product.
Diagnostic Suite™ represents a groundbreaking advancement in
medical imaging technology, offering the industry's first truly vertically integrated
solution. This comprehensive platform seamlessly unifies PACS, worklists, viewers, and
advanced visualization tools with cutting-edge AI capabilities.
Practices can leverage
everything from multi-format AI-enhanced reporting to remote acquisition and monitoring
through a single, cohesive interface.
Built on DeepHealth's OS, this all-in-one approach delivers
the scalability and functionality modern healthcare facilities need, while addressing
crucial market demands for enterprise imaging, workflow analytics, and operational
efficiency. As our flagship offering, Diagnostic Suite™ provides an end-to-end solution that
streamlines and elevates radiology workflows.
Somerville, MA, – August 7, 2025, DeepHealth, Inc., a wholly-owned subsidiary of RadNet, Inc. (NASDAQ: RDNT) and global leader in AI-powered health informatics, announced today that it has received FDA 510(k) clearance for TechLive™ – a remote scanning solution enabling centralized operation and supervision of MR, CT, PET/CT, and Ultrasound procedures.
Join DeepHealth at the 13th ESUR MRI Prostate Teaching Course to discover our AI solutions for prostate imaging. With the course focusing on AI in imaging, focal therapies, and prostate cancer screening, experience how our advanced algorithms enhance and support MRI interpretation. Our team will demonstrate how DeepHealth's technology integrates with prostate imaging workflows to improve diagnostic accuracy and clinical decision-making. Connect with leading experts and see how our AI platform is advancing prostate cancer detection and management across Europe.
November 11, 2024: Today, GE HealthCare (Nasdaq: GEHC) and DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), announced a strategic collaboration to further the innovation, commercialization, and adoption of AI in imaging.
Disclaimers:
Not all products and functionalities are commercially available in all countries. For clearance and commercial
availability in your geography of functionalities listed and compatibility with other systems, please contact us